ArticleMolecular pharmacology2020

Characterization and Optimization of the Novel Transient Receptor Potential Melastatin 2 Antagonist tatM2NX.

I Cruz-Torres et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.